2024. 05. 20.  21:59:55 Vált. +0,52 Forgalom (db) Vétel- Eladás- Piaci kapitalizáció Osztalékh. P/E Ráta
16,81USD +3,16% 299 635
Forgalom: 5,01 mill.
-Vétel (db): - -Eladás (db): - 19,04 mrd.USD - -

Cégbemutató

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day. Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,800 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies.
 

Igazgatóság & Felügyelőbizottság

CEO
Kåre Schultz
Igazgatóság
Eli Kalif, David M. Stark, Dr. Hafrun Fridriksdottir, Eli Shani, Eric Drapé, Galia Inbar, Lori Queisser, Mark Sabag, Nir Baron, Richard Daniell, Sven Dethlefs
Felügyelőbizottság
Dr. Sol J. Barer, Amir Elstein, Dr. Perry D. Nisen, Dr. Tal Zaks, Gerald M. Lieberman, Janet S. Vergis, Jean-Michel Halfon, Kåre Schultz, Nechemia J. Peres, Prof. Ronit Satchi-Fainaro, Roberto A. Mignone, Rosemary A. Crane
 

Cégadat

Név: Teva Pharmaceuticals Industries Ltd.
Cím: 5 Basel St.,Petach Tikva 49131, Israel
Telefon: +972-3-914-8171
Fax: +972-3-914-8678
E-mail: -
Internet: www.tevapharm.com
Ipar: Gyógyászat
Szektor: Gyógyszeripar
Alszektor: Gyógyszerek
Pénzügyi év vége: 12. 31.
Közkézhányad: 88,20%
IPO dátum: -

Befektetői kapcsolatok

Név: Kevin C. Mannix
IR telefon: +215-591-8912
IR Fax: -
IR e-mail: kevin.mannix@tevapharm.com

Fő részvényesek

Freefloat
 
88,20%
Capital Research and Management Company
 
11,80%